Anti-oxidative and anti-neuroinflammatory effects of ethyl acetate extract fractions of Suaeda asparagoides MIq
Cobertura |
Origin of publication: Nigeria |
---|---|
Data(s) |
21/09/2016
|
Resumo |
Purpose: To evaluate the in vitro antioxidant and anti-neuroinflammatory effects of Suaeda asparagoides ethylacetate extract (SAE) in lipopolysaccharide (LPS)-stimulated BV-2 microglial cells. Methods: The antioxidative activity of SAE was evaluated by measuring 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical scavenging activity spectrometrometrically. Cell viability was evaluated by 3-(4, 5dimethylthiazol-2-yl)-2, 5- diphenyl-tetrazolium bromide (MTT) assay, while LPS-stimulated BV-2 microglia were used to study the expression and production of inflammatory mediators, including nitric oxide (NO), inducible NO synthase (iNOS) and tumor necrosis alpha (TNF-α). Results: Pretreatment with SAE prior to LPS treatment significantly inhibited excessive production of NO (p < 0.001 at 20, 40, 80 and 100 μg/mL) in a dose-dependent manner, and was associated with down-regulation of expression of inducible nitric oxide synthase (iNOS). SAE also suppressed the LPSinduced increase in TNF-α level (p < 0.01at concentrations of 40 and 80 μg/mL) in BV-2 cells. Furthermore, DPPH-generated free radicals were inhibited by SAE in a concentration-dependent manner. Conclusion: These results indicate that SAE possesses strong anti-oxidant properties, and inhibits excessive production of pro-inflammatory mediators, including NO, iNOS and TNF-α, in LPS-stimulated BV-2 cells |
Formato |
html |
Identificador | |
Idioma(s) |
en |
Publicador |
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria |
Relação |
http://www.tjpr.org; http://www.bioline.org.br/pr |
Direitos |
Copyright 2016 - Tropical Journal of Pharmaceutical Research |
Fonte |
Tropical Journal of Pharmaceutical Research (ISSN: 1596-5996) Vol 15 Num 6 |
Palavras-Chave | #Suaeda asparagoides; DPPH; Anti-inflammatory activity; Microglial cells; iNOS; TNF-α |
Tipo |
AA |